Cargando…
An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women
Uncomplicated recurrent urinary tract infections (rUTIs) in women are associated with episodic bothersome symptoms and have a significant impact on the mental and physical quality of life. Treatment with antibiotics (short- and long-term dosing) results in acute and chronic side effects and costs an...
Autores principales: | Nickel, J. Curtis, Doiron, R. Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052183/ https://www.ncbi.nlm.nih.gov/pubmed/36986281 http://dx.doi.org/10.3390/pathogens12030359 |
Ejemplares similares
-
MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection
por: Saz-Leal, Paula, et al.
Publicado: (2023) -
Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections
por: Lorenzo-Gómez, María F., et al.
Publicado: (2015) -
Cost-Effectiveness of a Sublingual Bacterial Vaccine for the Prophylaxis of Recurrent Urinary Tract Infections
por: Carrión-López, Pedro, et al.
Publicado: (2022) -
A sublingual nanofiber vaccine to prevent urinary tract infections
por: Kelly, Sean H., et al.
Publicado: (2022) -
Enlisting Probiotics to Combat Recurrent Urinary Tract Infections in Women—A Military Strategy for Meeting the Challenge
por: Watson, Richard A.
Publicado: (2023)